Lidocaine Ointment Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-04-02　·　156 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 1.95 Bn
2033 年預估規模: USD 3.12 Bn
年複合成長率 CAGR: 6.9%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-04-02頁數 156報告編號 CMI5434

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Lidocaine Ointment Market, By Formulation (Internal Use, Topical Use), By Age Group (Children, Adult), By Application (Insect Bite, Sun Burn, Minor Cut, Mouth Sore, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals and Clinics and Ambulatory Surgery Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Topical lidocaine ointment is used on various parts of the body to cause loss of sensation in patients undergoing certain medical procedures, such as surgery. It is also used to relieve pain and itching caused by conditions such as sun burn, poison ivy, poison oak, minor cuts and abrasions. It is also used to prevent and control pain during urethral surgery in both men and women. Lidocaine is a local anesthetic commonly used for local anesthesia, but it is also used as an antiarrhythmic and analgesic drug and also used as an adjutant to endotracheal intubation. It is a tertiary amine and an antiarrhythmic drug according to the Vaughan-Williams classification. Lidocaine acts as a valuable tool in anesthesiology, cardiology, and pain management. In plasma, lidocaine has 65% of its protein bound to albumin and alpha 1 acid glycoprotein, giving it an intermediate duration of action compared to other local anesthetics. Lidocaine ointment are used to numb the lining of the mouth or throat before certain medical/dental procedures. Market Dynamics The increasing research and development activities of lidocaine ointment for product expansion by the key players in the market, which is expected to drive the market growth over the forecast period. For instance, in January 2021, The Mayo Clinic in Arizona has initiated a clinical study comparing two local anesthetics for fractional non-ablative laser treatment of the face. 2.5 g lidocaine 23%/tetracaine 7% ointment is in Phase 2 and 7.5 g lidocaine 2.5%/prilocaine 2.5% cream is in Phase 3 clinical trials. The scheduled completion date is January 2023. Key features of the study • This report provides an in-depth analysis of the global lidocaine ointment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global lidocaine ointment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Glenmark Pharmaceuticals U.S. Inc., Teligent Inc., Taro Pharmaceutical Industries Ltd., CENTURA PHARMACEUTICALS INC., Neon Laboratories Ltd., ASTRAZENECA CANADA INC., Novocol Pharma, Amneal Pharmaceuticals LLC., Alembic Pharmaceuticals Limited, Ascend Laboratories LLC, Liberty Pharmaceuticals, Inc., Hi-Tech Pharmaceuticals, Aspen Pharmacare Australia Pty Ltd., Sandoz AG, Zydus Healthcare Limited., Quagen Pharmaceuticals, Zuche Pharmaceuticals Private Limited., and SEPTODONT, Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global lidocaine ointment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lidocaine ointment market Market Segmentation • Global Lidocaine Ointment Market, By Formulation o Internal Use o Topical Use • Global Lidocaine Ointment Market, By Age Group o Children o Adult • Global Lidocaine Ointment Market By Application o Insect Bite o Sun Burn o Minor Cut o Mouth Sore o Others • Global Lidocaine Ointment Market By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Global Lidocaine Ointment Market, By Region o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  ASEAN  Australia  South Korea  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Glenmark Pharmaceuticals U.S. Inc. o Taro Pharmaceutical Industries Ltd. o CENTURA PHARMACEUTICALS INC. o Neon Laboratories Ltd. o ASTRAZENECA CANADA INC. o Novocol Pharma o Amneal Pharmaceuticals LLC. o Alembic Pharmaceuticals Limited o Ascend Laboratories LLC o Liberty Pharmaceuticals, Inc. o Hi-Tech Pharmaceuticals o Aspen Pharmacare Australia Pty Ltd. o Sandoz AG o Zydus Healthcare Limited. o Quagen Pharmaceuticals o Zuche Pharmaceuticals Private Limited. o SEPTODONT, Inc. o Teligent Inc.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Formulation  Market Snapshot, By Age Group  Market Snapshot, By Application  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Attractiveness Analysis  Market Opportunities o Product Launches o Merger, Acquisition, Collaborations o Pipeline Analysis o Regulatory Guideline and Compliances o Government Intervention o PEST Analysis o Technology Landscape o Brand Attribute Mapping o Investments 4. Global Lidocaine Ointment Market, By Formulation, 2021 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2022 and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Internal Use  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Topical Use  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) 5. Global Lidocaine Ointment Market, By Age Group, 2021 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2022 and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Children  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Adult  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) 6. Global Lidocaine Ointment Market, By Application, 2021 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2022 and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segments Trends o Insect Bite  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Sun Burn  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Minor Cut  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Mouth Sore  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) 7. Global Lidocaine Ointment Market, By Distribution Channel, 2021 – 2033, (USD Bn) o Introduction  Market Share Analysis, 2022 and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segments Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) 8. Global Lidocaine Ointment Market, By Region, 2021 – 2033, (USD Bn) o Introduction  Market Share Analysis, By Region, 2022 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2021–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn) o North Africa o Central Africa o South Africa 9. Competitive Landscape o Glenmark Pharmaceuticals U.S. Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Teligent Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Taro Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o CENTURA PHARMACEUTICALS INC.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Neon Laboratories Ltd  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o ASTRAZENECA CANADA INC.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novocol Pharma  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o ABneal Pharmaceuticals LLC  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Alembic Pharmaceuticals Limited  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Ascend Laboratories LLC  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Liberty Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Hi-Tech Pharmaceuticals  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Aspen Pharmacare Australia Pty Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Sandoz AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Zydus Healthcare Limited  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Quagen Pharmaceuticals  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Zuche Pharmaceuticals Private Limited.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o SEPTODONT, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 10. Section o Research Methodology o About Us

提及公司

Glenmark Pharmaceuticals U.S. Inc.Taro Pharmaceutical Industries Ltd.CENTURA PHARMACEUTICALS INC.Neon Laboratories Ltd.ASTRAZENECA CANADA INC.Novocol PharmaAmneal Pharmaceuticals LLC.Alembic Pharmaceuticals LimitedAscend Laboratories LLCLiberty Pharmaceuticals, Inc.Hi-Tech PharmaceuticalsAspen Pharmacare Australia Pty Ltd.Sandoz AGZydus Healthcare Limited.Quagen PharmaceuticalsZuche Pharmaceuticals Private Limited.SEPTODONT, Inc.Teligent Inc.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們